In this article, we analyze in depth the possible interaction between cannabidiol (CBD), a molecule derived from cannabis, and montelukast, a medication used to treat the symptoms of asthma and certain types of allergies. Let’s examine in more detail what these two compounds are, their effects, and why it’s important to understand their potential interactions. What is CBD? Cannabidiol, or CBD, is one of the many cannabinoids found in the cannabis plant. Unlike tetrahydrocannabinol (THC), which is responsible for the psychoactive effects typical of cannabis, CBD does not produce intoxication and has been extensively studied for its potential therapeutic properties. Some of the main current applications of CBD include:Anxiety disorders
Sommaire
ToggleChronic pain
Sleep disorders
- Symptoms of certain neurological diseases (such as multiple sclerosis or epilepsy). Due to its generally mild side effect profile and versatility, CBD has gained popularity as an alternative or complementary treatment to various conventional medical therapies.
- What is montelukast?
- Montelukast is a medication widely used to treat the symptoms of asthma and certain types of allergies. It belongs to the class of leukotriene receptor antagonists, acting specifically on the CysLT1 receptor, which plays a key role in the inflammatory processes involved in these conditions.
Marketed under various names such as Singulair or Montelukast-ratiopharm, this medication is primarily prescribed for: Preventing asthma attacksTreating seasonal allergies (allergic rhinitis)
Reducing the frequency of nighttime awakenings due to asthma
CBD and montelukast: Are there any potential interactions?
Drug interactions often result from a process called competitive inhibition, where two or more molecules interact with the same enzymes or receptors, altering their respective activities. Researchers are increasingly interested in the interactions between cannabinoids and other drugs, as this could help in understanding how to optimize the therapeutic use of cannabis and its derivatives. In the case of CBD and montelukast, some data suggest a possible interaction.Both compounds are metabolized by cytochrome P450 (CYP) liver enzymes, specifically the CYP2C9 isoenzyme. When combined with certain molecules, CBD can inhibit these enzymes, leading to changes in how they metabolize other drugs, including montelukast.
- However,
- available data on this potential interaction remain limited and are primarily based on in vitro studies or animal models. To date, no clinical studies have been conducted to conclusively evaluate the practical impact of this combination in patients taking CBD and montelukast concurrently. Other factors such as dosage, route of administration, and frequency of treatment may also affect the level of interaction between these molecules in real-world situations.
Precautions to take when using CBD and montelukast together
It is important to note that the potential drug interactions identified here do not necessarily mean that these two substances should never be taken together. However, it is recommended to take certain precautions when considering combining CBD with montelukast:
Consult your doctor
Always inform your doctor if you are considering using CBD in addition to your usual montelukast treatment, so they can adjust the dosage accordingly or assess whether this combination is appropriate for you.
Monitor for side effects: If you are taking CBD and montelukast together, be alert to any changes in your symptoms or the appearance of unusual side effects, which may indicate an interaction. Discuss any concerns with your doctor during your treatment.Choose quality-controlled products: When selecting a CBD product, ensure it comes from a reputable source and has undergone rigorous testing to guarantee its quality and cannabinoid content.


